Cancer Cachexia clinical trials at UCLA

1 research study open to eligible people

NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
open to eligible people ages 18 years and up
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
Los Angeles, California and other locations

Last updated: March 30, 2026